Your browser doesn't support javascript.
loading
Plasma metabolomic markers underlying skeletal muscle mitochondrial function relationships with cognition and motor function.
Tian, Qu; Greig, Erin E; Walker, Keenan A; Fishbein, Kenneth W; Spencer, Richard G; Resnick, Susan M; Ferrucci, Luigi.
Afiliação
  • Tian Q; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Greig EE; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Walker KA; Laboratory of Behavioral Neuroscience, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Fishbein KW; Laboratory of Clinical Investigation, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Spencer RG; Laboratory of Clinical Investigation, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Resnick SM; Laboratory of Behavioral Neuroscience, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Ferrucci L; Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
Age Ageing ; 53(4)2024 04 01.
Article em En | MEDLINE | ID: mdl-38615247
ABSTRACT

BACKGROUND:

Lower skeletal muscle mitochondrial function is associated with future cognitive impairment and mobility decline, but the biological underpinnings for these associations are unclear. We examined metabolomic markers underlying skeletal muscle mitochondrial function, cognition and motor function.

METHODS:

We analysed data from 560 participants from the Baltimore Longitudinal Study of Aging (mean age 68.4 years, 56% women, 28% Black) who had data on skeletal muscle oxidative capacity (post-exercise recovery rate of phosphocreatine, kPCr) via 31P magnetic resonance spectroscopy and targeted plasma metabolomics using LASSO model. We then examined which kPCr-related markers were also associated with cognition and motor function in a larger sample (n = 918, mean age 69.4, 55% women, 27% Black).

RESULTS:

The LASSO model revealed 24 metabolites significantly predicting kPCr, with the top 5 being asymmetric dimethylarginine, lactic acid, lysophosphatidylcholine a C181, indoleacetic acid and triacylglyceride (171_343), also significant in multivariable linear regression. The kPCr metabolite score was associated with cognitive or motor function, with 2.5-minute usual gait speed showing the strongest association (r = 0.182). Five lipids (lysophosphatidylcholine a C181, phosphatidylcholine ae C423, cholesteryl ester 181, sphingomyelin C260, octadecenoic acid) and 2 amino acids (leucine, cystine) were associated with both cognitive and motor function measures.

CONCLUSION:

Our findings add evidence to the hypothesis that mitochondrial function is implicated in the pathogenesis of cognitive and physical decline with aging and suggest that targeting specific metabolites may prevent cognitive and mobility decline through their effects on mitochondria. Future omics studies are warranted to confirm these findings and explore mechanisms underlying mitochondrial dysfunction in aging phenotypes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfatidilcolinas / Disfunção Cognitiva Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfatidilcolinas / Disfunção Cognitiva Idioma: En Ano de publicação: 2024 Tipo de documento: Article